Azenet Reeves
About Azenet Reeves
Azenet Reeves serves as the Director of Business Operations at HTG Molecular Diagnostics since 2021, bringing extensive experience from various roles in the medical diagnostics field, particularly at Ventana Medical Systems.
Work at HTG Molecular Diagnostics
Azenet Reeves has been serving as the Director of Business Operations at HTG Molecular Diagnostics since 2021. In this role, she oversees various operational aspects of the business, contributing to the company's strategic objectives in the molecular diagnostics field. Prior to her current position, she held multiple roles within the same organization, including Senior Manager of Business Operations and Manager of Business Operations, accumulating a total of ten years of experience at HTG Molecular Diagnostics.
Previous Experience at Ventana Medical Systems
Before joining HTG Molecular Diagnostics, Azenet Reeves worked at Ventana Medical Systems for over a decade. Her roles included Business Analyst, Project Coordinator, and Contract Administrator, among others. She began her tenure there as a Clinical Research Associate and progressed through various positions, including CC/Contract/Pricing Team Lead and International CCE. This extensive experience provided her with a solid foundation in business operations and project management.
Education and Expertise
Azenet Reeves studied at Danville Area Community College, where she earned an Associate of Science (AS) degree. She furthered her education at Illinois State University. Her academic background, combined with her extensive professional experience, has equipped her with the skills necessary for her roles in business operations and management within the diagnostics industry.
Career Progression
Azenet Reeves has demonstrated significant career progression throughout her professional journey. Starting as a Clinical Research Associate at Ventana Medical Systems in 2000, she advanced through various roles, gaining expertise in contract compliance, project coordination, and business analysis. Her transition to HTG Molecular Diagnostics allowed her to take on leadership roles, culminating in her current position as Director of Business Operations.